World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
41193
World Ranking
7917
National Ranking
4121

Overview

Lynette M. Sholl is affiliated with Brigham and Women's Hospital in the United States. Their research spans multiple domains within medicine, focusing particularly on pulmonary and respiratory medicine, oncology, and molecular biology. The scientist's published works demonstrate a significant contribution to fields such as cancer research and surgery, integrating molecular biology techniques and clinical approaches.

The primary areas of study for Lynette M. Sholl include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these broader fields, their subfields consist of:

  • Pulmonary and Respiratory Medicine
  • Oncology
  • Cancer Research
  • Molecular Biology
  • Surgery

The scientist's research covers a range of topics emphasizing lung and cancer-related investigations:

  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal Cancer Treatments and Studies

Lynette M. Sholl has a record of frequent collaboration with several other researchers, including:

  • Mark M. Awad
  • Biagio Ricciuti
  • Jennifer Gordetsky
  • Joao V. Alessi
  • Karen Fritchie

Publications by Lynette M. Sholl appear regularly in specialized journals. The most common publication venues include:

  • Modern Pathology
  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Laboratory Investigation
  • Clinical Cancer Research

Recent papers spotlighting diverse aspects of lung cancer and biomarkers include:

  • "PD-L1 as a biomarker of response to immune-checkpoint inhibitors," 2021, Nature Reviews Clinical Oncology
  • "The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015," 2021, Journal of Thoracic Oncology
  • "Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer," 2021, Journal of Thoracic Oncology
  • "A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee," 2020, Journal of Thoracic Oncology
  • "IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy," 2020, Journal of Thoracic Oncology

Best Publications

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    Neal I. Lindeman;Philip T. Cagle;Dara L. Aisner;Maria E. Arcila

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

    Ferdinandos Skoulidis;Michael E. Goldberg;Danielle M. Greenawalt;Matthew D. Hellmann

  • PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    Deborah Blythe Doroshow;Sheena Bhalla;Mary Beth Beasley;Lynette M. Sholl

  • Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors

    Esra A. Akbay;Esra A. Akbay;Shohei Koyama;Julian Carretero;Abigail Altabef;Abigail Altabef

  • The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.

    Andrew G. Nicholson;Ming S. Tsao;Mary Beth Beasley;Alain C. Borczuk

  • Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1

    Brooke Elizabeth Howitt;Sachet Shukla;Lynette Marie Sholl;Lauren Lee Ritterhouse

  • MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

    Mark Magdi Awad;Geoffrey Raymond Oxnard;David M Jackman;Daniel O. Savukoski

  • Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.

    Geoffrey R. Oxnard;Geoffrey R. Oxnard;Yuebi Hu;Kathryn F. Mileham;Hatim Husain

  • Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

    Christian Rolfo;Philip C. Mack;Giorgio V. Scagliotti;Paul Baas

  • Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    Diana Miao;Diana Miao;Claire A. Margolis;Claire A. Margolis;Natalie I. Vokes;Natalie I. Vokes;David Liu;David Liu

  • PD-1 Inhibitor–Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course

    Mizuki Nishino;Nikhil H. Ramaiya;Mark M. Awad;Lynette M. Sholl

  • Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: The lung cancer mutation consortium experience

    Lynette M. Sholl;Dara L. Aisner;Marileila Varella-Garcia;Lynne D. Berry

  • Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.

    Elizabeth P. Garcia;Alissa Minkovsky;Yonghui Jia;Matthew D. Ducar

  • Acquired Resistance to KRASG12C Inhibition in Cancer

    Mark M Awad;Shengwu Liu;Igor I Rybkin;Kathryn C Arbour

  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    Christian Rolfo;Philip Mack;Giorgio V. Scagliotti;Charu Aggarwal

  • Institutional implementation of clinical tumor profiling on an unselected cancer population

    Lynette M. Sholl;Khanh Do;Priyanka Shivdasani;Ethan Cerami

  • Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma

    Daniel E. Bauer;Chelsey M. Mitchell;Kelly M. Strait;Christopher S. Lathan

  • Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.

    Stephanie Cardarella;Atsuko Ogino;Mizuki Nishino;Mohit Butaney

  • The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy

    Ruth Scherz-Shouval;Sandro Santagata;Sandro Santagata;Sandro Santagata;Marc L. Mendillo;Lynette Marie Sholl

  • Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy

    Nishino M;Sholl Lm;Hodi Fs;Hatabu H

Frequent Co-Authors

Pasi A. Jänne
Pasi A. Jänne Harvard University
Mark M. Awad
Mark M. Awad Harvard University
Mizuki Nishino
Mizuki Nishino Harvard University
Neal I. Lindeman
Neal I. Lindeman Brigham and Women's Hospital
Eliezer M. Van Allen
Eliezer M. Van Allen Harvard University
Scott J. Rodig
Scott J. Rodig Harvard University
Jason L. Hornick
Jason L. Hornick Brigham and Women's Hospital
Mari Mino-Kenudson
Mari Mino-Kenudson Harvard University
Yasushi Yatabe
Yasushi Yatabe Nagoya University
Levi A. Garraway
Levi A. Garraway Roche (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to a wide range of healthcare careers—and not just for future physicians. Today, diverse online degree programs make it easier than ever to study key medical and health-related fields while maintaining flexibility.

For those interested in leadership roles within healthcare organizations, pursuing online mha programs affordable is an accessible path. These programs teach management skills crucial for running hospitals or clinics. Aspiring advanced practice nurses can consider cheap dnp online programs, which provide advanced clinical expertise and specialized skills.

If your passion is pharmacy, you’ll find several pharmacy school online options that prepare students for pharmacy licensure and practice. For those interested in patient data and information systems, consider earning your credentials through an online mhi program.

Each of these career pathways leverages the flexibility and affordability of online education—helping you advance in the rapidly expanding field of healthcare.

Best Scientists Citing Lynette M. Sholl

Trending Scientists